RAPATAG Trademark
Trademark Overview
On Wednesday, May 22, 2024, a trademark application was filed for RAPATAG with the United States Patent and Trademark Office. The USPTO has given the RAPATAG trademark a serial number of 98563083. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 22, 2024. This trademark is owned by Rapafusyn Pharmaceuticals, Inc.. The RAPATAG trademark is filed in the Metal Products and Leather Products categories with the following description:
medicines and pharmaceutical preparations; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets by by bringing two proteins together; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets by bringing two proteins together in a noncovalent manner
chemicals and chemical compositions; chemicals and chemical compositions for use in modulating disease targets; chemicals and chemical compositions for use in modulating disease targets by bringing two proteins together; chemicals and chemical compositions for use in modulating disease targets by bringing two proteins together in a noncovalent manner
General Information
Serial Number | 98563083 |
Word Mark | RAPATAG |
Filing Date | Wednesday, May 22, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Wednesday, May 22, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | medicines and pharmaceutical preparations; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets by by bringing two proteins together; medicines and pharmaceutical preparations and ingredients therefor for use in modulating disease targets by bringing two proteins together in a noncovalent manner |
Goods and Services | chemicals and chemical compositions; chemicals and chemical compositions for use in modulating disease targets; chemicals and chemical compositions for use in modulating disease targets by bringing two proteins together; chemicals and chemical compositions for use in modulating disease targets by bringing two proteins together in a noncovalent manner |
Pseudo Mark | RAPA TAG |
Classification Information
International Class | 006 - Common metals and their alloys; metal building materials; transportable buildings of metal; materials of metal for railway tracks; nonelectric cables and wires of common metal; ironmongery, small items of metal hardware; pipes and tubes of metal; safes; goods of common metal not included in other classes; ores. |
US Class Codes | 002, 012, 013, 014, 023, 025, 050 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, May 22, 2024 |
Primary Code | 006 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 018 - Leather and imitations of leather, and goods made of these materials and not included in other classes; animal skins, hides; trunks and traveling bags; umbrellas, parasols and walking sticks; whips, harness and saddlery. |
US Class Codes | 001, 002, 003, 022, 041 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, May 22, 2024 |
Primary Code | 018 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Rapafusyn Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Grand Cayman KY1-1106 KY |
Trademark Events
Event Date | Event Description |
Wednesday, May 22, 2024 | NEW APPLICATION ENTERED |
Tuesday, November 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |